Pulmonx (LUNG) Short-term Investments (2019 - 2025)
Pulmonx's (LUNG) quarterly Short-term Investments came in at $8.8 million in Q2 2025, down 82.85% year-on-year from $51.1 million in Q2 2024, and down 38.09% on a QoQ basis from $14.1 million in Q1 2025.
Pulmonx (LUNG) Short-term Investments (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 6 years of Short-term Investments data on file, last reported at $8.8 million in Q2 2025.
- On a quarterly basis, Short-term Investments fell 82.85% year-over-year to $8.8 million in Q2 2025; TTM through Jun 2025 was $8.8 million, a 82.85% decrease from a year earlier, with the FY2024 full-year figure at $30.6 million, down 8.87% from the prior year.
- Short-term Investments for Q2 2025 stood at $8.8 million, down from $14.1 million in the prior quarter.
- Over the last five years, Short-term Investments for LUNG reached as high as $51.1 million in Q2 2024 and fell as low as $8.8 million in Q2 2025.
- Historically, Short-term Investments has averaged $30.8 million across 5 years, with a median of $33.6 million in 2023.
- Across the five-year window, Short-term Investments soared 318.17% in 2022 and tumbled 82.85% in 2025, its largest moves.
- Year by year, Short-term Investments stood at $31.6 million in 2021, then increased by 24.84% to $39.4 million in 2022, then decreased by 14.84% to $33.6 million in 2023, then fell by 8.87% to $30.6 million in 2024, then tumbled by 71.35% to $8.8 million in 2025.
- Per Business Quant data, the three most recent Short-term Investments figures were $8.8 million in Q2 2025, $14.1 million in Q1 2025, and $30.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 14.15 Mn |
| Dec 31, 2024 | 30.58 Mn |
| Sep 30, 2024 | 44.47 Mn |
| Jun 30, 2024 | 51.08 Mn |
| Mar 31, 2024 | 45.97 Mn |
| Dec 31, 2023 | 33.56 Mn |
| Sep 30, 2023 | 21.54 Mn |
| Jun 30, 2023 | 33.57 Mn |
| Mar 31, 2023 | 42.43 Mn |
| Dec 31, 2022 | 39.40 Mn |
| Sep 30, 2022 | 44.50 Mn |
| Jun 30, 2022 | 40.14 Mn |
| Mar 31, 2022 | 40.91 Mn |
| Dec 31, 2021 | 31.56 Mn |
| Sep 30, 2021 | 11.77 Mn |
| Jun 30, 2021 | 10.77 Mn |
| Mar 31, 2021 | 9.78 Mn |
| Dec 31, 2019 | 13.58 Mn |